Max Robotics — Global Service Robot Directory + US Certification

About

Ranjit Manchanda is a leading figure in gynecologic oncology and cancer prevention, with a research focus on risk-reducing strategies, hereditary cancer syndromes, and health service delivery. His major contributions include pioneering work on population-based genetic testing for BRCA mutations, demonstrating its feasibility and cost-effectiveness in preventing ovarian and breast cancers. His influential studies have shaped international guidelines on risk-reducing salpingo-oophorectomy and screening protocols. With over 20,000 citations, his work has had a profound impact on clinical practice and public health policy. Notably, his research on "Gynecologic Oncology Training Systems in Europe" (2011) highlighted disparities in surgical education, driving reforms in training standards. Manchanda has also led landmark trials on ovarian cancer screening and prevention, earning him recognition as a thought leader in the field. His dedication to translating genetic discoveries into actionable prevention strategies continues to inspire a new generation of researchers and clinicians.